Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polyphenon E in Men With HGPIN or ASAP
NCT00596011Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Nov 2007
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in prostate cancer (PCa) comparing Polyphenon E Treatment with Placebo Administration (2 arms). Primary endpoints: Rate of Progression to Prostate Cancer at 12 months and Rate of Progression From HGPIN to ASAP or PCa at 12 months. Started Nov 2007; status: completed.
02
Drugs
green tea extract
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00596011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00596011.